Cures & Capital

Stephan Christgau on applying the VC mindset in biotech & pharma

Martin Slezak and Simon Birksø

How do venture capitalists think? And how do they define and create value in the life science industry?

In this episode, we talk to Stephan Christgau, founding partner of Eir Ventures, about the VC mindset, investment decision-making and portfolio strategy. We dive into how VCs assess risk, balance high-stakes opportunities, and what could pharma and biotech companies learn from the VC way of doing things.

If you want to connect with us - we would love to hear from you:
Linkedin: https://www.linkedin.com/company/cures-capital-podcast

If you prefer to get the episodes as a video, you can watch our talking heads on YouTube.

If you want to connect with Stephan or read about Eir Ventures:
Linkedin: https://www.linkedin.com/in/stephan-christgau-6464392/
Eir Ventures: https://www.linkedin.com/company/eir-ventures/

Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

Disclaimer: This podcast and activities related to it are completely independent from our day jobs. All the views and opinions expressed through this channel are solely our own and do not represent or in any way reflect the views and opinions of the companies we work for.

People on this episode